Denali Therapeutics Inc. (DNLI)
undefined
undefined%
At close: undefined
22.97
0.04%
After-hours Dec 13, 2024, 04:15 PM EST

Denali Therapeutics Inc. Forcast

Stock Price Forecast

The 11 analysts with 12-month price forecasts for DNLI stock have an median target of 32, with a low estimate of 22 and a high estimate of 50. The median target predicts an increase of 39.37% from the current stock price of 22.96.

Analyst Consensus: Buy
Target Low Average Median High
Price $22 $33.22 $32 $50
Change -4.18% 44.69% 39.37% 117.77%

AI Analyst Report

HC Wainwright & Co. has reaffirmed a Buy rating on... Unlock content with Pro Subscription

Updated Nov 07, 2024

Rating May 24Jul 24Aug 24Sep 24Oct 24Nov 24
Strong Buy 001101
Buy 213211
Hold 100010
Sell 000000
Strong Sell 000000
Total 3 1 4 3 2 2

Financial Forecast this Year

Revenue This Year
21.50M
from 330.53M
Increased by -93.5%
Revenue Next Year
68.78M
from 21.50M
Increased by 219.9%
EPS This Year
-2.53
from -1.06
Increased by -138.7%
EPS Next Year
-2.66
from -2.53
Increased by -5.1%